GenWand™ dsDNA demonstrated 80% higher KI efficiency compare to in-house PCR dsDNA (38% vs 21%)
dsDNA
Length (bp) | Price Starting From |
---|---|
1000 | $650 |
3000 | $1850 |
5000 | $2050 |
10000 | $2300 |
Starting at 10 µg/item. Delivered in as fast as 3 weeks.
Test Specifications | Detection Method | Release Criteria | Research Grade |
---|---|---|---|
Purity | Agarose gel electrophoresis | Single band |
✔
|
Sequence accuracy | Sanger sequencing | 100% sequence alignment |
✔
|
Optical density | Spectrophotometer at 260 nm/230 nm | ≥ 2.0 |
✔
|
CRISPR based gene insertion, replacement, or correction
Mechanism of CRISPR HDR based gene editing
CRISPR/Cas9 is currently the most widely used to system for gene editing due to its simplicity, efficiency, precision, and versatility. In this system, the guide RNA (gRNA) recognizes the protospacer adjacent motif (PAM) sequence on the target DNA. Upon forming a complex with Cas9, the enzyme exerts its endonuclease function to create a double-stranded break (DSB). This triggers one of two primary mechanisms for repair: non-homologous end-joining (NHEJ), which introduces mutations at the DSB site, or homology-directed repair (HDR), which enables the insertion of donor DNA at the break site to achieve gene knock-in.
Double-stranded DNA (dsDNA) has long been a standard choice for HDR donor DNA templates in CRISPR knock-in applications. However, studies show that closed-end dsDNA offers distinct advantages over traditional open-end dsDNA. Closed-end structures reduce exonuclease degradation and improve stability, leading to higher editing efficiency and lower rates of off-target integration. This format is particularly ideal for knocking in long or complex sequences, and the process used to produce GenWand™ dsDNA also makes it advantageous for conducting large-scale screening or scale up.
CRISPR Knock-in Protocol for HEK 293T/293 cells with Thermo Fisher Neon®
Transfection System
CRISPR Knock-in Protocol for Jurkat cells with Thermo Fisher Neon® Transfection
System
CRISPR Knock-in Protocol for stimulated Human T Cells with Lonza 4D Nucleofector™
X Unit
CRISPR Knock-in Protocol for stimulated Human T Cells with Maxcyte®
Electroporation System
Design and Preparation Guidelines for CRISPR KI HDR Templates
Our linear GenWand dsDNA provides the following advantages over PCR dsDNA:
To produce linear GenWand dsDNA, ssDNA is first produced from a 100% sequenced verified plasmid DNA template. The ssDNA is then cloned into a universal vector and replicated in E. coli to ensure the highest sequence fidelity. Last, special enzymes are added to produce high purity closed-end dsDNA.
We can produce linear GenWand dsDNA up to 10 kb in length.
We can provide up to a gram per batch of linear GenWand dsDNA. However, the yield is dependent on the length and difficulty of the ssDNA sequence.
We provide two primary QC tests for our RUO grade GenWand dsDNA templates:
Reach out to a CRISPR expert at crispr@genscript.com if you're interested in learning about quality control for our cGMP and GMP-like GenWand dsDNA templates.
During the production of dsDNA, we do two rounds of sequencing to guarantee the sequence accuracy. We first pick a sequence-verified plasmid DNA template via sequencing to ensure the purity and sequence accuracy of the final dsDNA product. In addition, we use direct sequencing on the final dsDNA product to confirm the dsDNA product homogeneity.
Column chromatography is used to purify the final linear dsDNA product upon restriction enzyme digestion.
Linear GenWand dsDNA can be delivered in single tubes or 96-well plates, either as dry powder or suspended in TE buffer or nuclease-free water at the concentration of your choice (up to 3mg/ml).
GenWand dsDNA are stable for at least six (6) months. Please store at -20 °C and avoid repeated freeze and thaw cycles. Avoid repeated freeze-thaw cycles after dissolving as well. If necessary, divide the stock solution into small aliquots and only thaw the amount needed for each test.
For more information, please refer to the GenWand dsDNA User Manual and our KI protocols.
The quantity of linear GenWand dsDNA used for each test will depend on your specific application. For ex-vivo cell editing, we typically use 2-4 ug/million cells in our protocol.
Yes! We offer Knock-in Optimization Kits (KIOK) to help you effectively optimize your CAR insertion process with a pre-validated sequence, design, and protocol. By choosing this pre-designed kit, you can achieve up to 75% in cost savings compared to ordering customized synthesis services! Learn more here.
A CTS sequence is designed to allow the HDR template to interact with the sgRNA/Cas9 RNP to increase delivery of the template to the nucleus. While it is recommended to add a CTS to the 5'-end of ssDNA HDR templates, this is not the case for dsDNA templates. It has been observed that exogenous DNA (including linear dsDNA templates) can be cytotoxic at high doses and its enhanced delivery can reduce cell viability.1
1 https://www.semanticscholar.org/paper/Polymer-stabilized-Cas9-nanoparticles-and-modified-Nguyen-Roth/dc6ea29f77ed548e76526337e5dbae22425a5804
Yes, we offer a variety of protocols that include step-by-step instructions for HDR knock-ins with some of the most commonly used electroporators, including the Thermo Fisher Neon® Transfection System and MaxCyte® Electroporation Platform.
You can view and download them for free here.
Yes, we proudly offer cGMP (and GMP-like) grade templates in our GenExact ssDNA and GenWand linear dsDNA formats. These services allow you to seamlessly advance your cell or gene therapy program to IND filing and clinical trials faster and more efficiently through a single vendor. Learn more about our cGMP services here.